BREAKING SILOS TO TRANSFORM WOMEN’S HEALTH THROUGH MEDTECH Inaugural Summit discusses new evidence in inequities affecting diagnosis, treatment and innovation
With
Jasjit Baveja PhD,
Director of Regulatory and Industry Policy,
Medical Technology Association of Australia (MTAA)
SEGMENT
Filmed in Sydney | July 2026
In an interview with Australian Health Journal, Jasjit Baveja, Director of Regulatory and Industry Policy at the Medical Technology Association of Australia (MTAA), highlighted the growing importance of medical technology in addressing longstanding inequities in women’s health.
Drawing on the outcomes of the inaugural MTAA Women’s Health MedTech Summit, she explained how the event brought together clinicians, researchers, industry leaders, regulators, investors, government representatives and patient advocates to tackle complex challenges through a collaborative approach.
Baveja said the summit was intentionally designed to break down traditional barriers between stakeholders, noting that, “it doesn’t matter who it was, they were all describing different parts of the same problem.” Discussions extended well beyond reproductive and sexual health to examine conditions that affect women exclusively, differently or disproportionately across every stage of life.
The summit identified several key barriers, including delayed diagnosis, gaps in clinical evidence, medical device design that often fails to account for women’s needs, and regulatory and reimbursement challenges. Baveja also highlighted compelling statistics that demonstrate persistent gender disparities in research and healthcare, reinforcing the need for greater investment in women’s health across the entire medical technology lifecycle.
Importantly, she said the discussions reinforced that women’s health is no longer a niche issue, but one with significant health, workforce, economic and innovation implications.
Looking ahead, Baveja said there was “strong support to move from conversation to action,” with MTAA committing to establish a Women’s Health Policy Group and develop a white paper outlining barriers, opportunities and policy recommendations to improve health outcomes for Australian women.
Source: Adapted from transcript
Media access credit: Medical Technology Association of Australia (MTAA)
You Might also like
-
MTAA MedTech19 Annual Conference
MTAA’s annual conference is the premier medical technology industry conference in Australia and brings together leaders and influencers across industry, government and academia to discuss what’s up ahead for the MedTech industry.
-
Awareness, diagnosis and treatment of Congenital Hypothyroidism
Australian Health Journal spoke to Associate Professor MIchelle Jack about congenital hypothyroidism and newborn screening and her concerns in the varying thresholds for across different states in Australia. Despite the existence of newborn screening programs since the 1970s, there is still controversy surrounding the appropriate screening levels. Congenital hypothyroidism, affecting about one in 3500 infants, can lead to severe intellectual and physical impairment if not diagnosed early. The condition is mainly caused by the thyroid gland’s failure to develop properly, resulting in insufficient thyroid hormone production.
-
Brain and Mind Implants Lived Experience Medical Technology Nervous System New Content New South Wales Spinal cord
LIVED EXPERIENCE: Complex Regional Pain Syndrome (CRPS)
Lachlan Thorpe has shared his experience of living with complex regional pain syndrome (CRPS), highlighting the profound impact the condition had on his life and the difference medical technology has made to his recovery.
In an interview with the Australian Health Journal, Thorpe explained that his CRPS developed following an ankle injury sustained while playing rugby for Sydney University Rugby Club in late 2024. After undergoing surgery and rehabilitation for the injury, he began experiencing severe pain, swelling and sensitivity despite there being no further orthopaedic damage.